AOD-9604 5mg vs 10mg: Choosing the Right Format for Your Research AOD-9604 is available from Ascend Peptides UK in both 5mg and 10mg formats
As we stated in the CY 2020 HPT final rule (84 FR 65571), we continue to encourage hospitals to provide consumers with cost information in a consumer-friendly manner
Treatment At Evolved Medical, BPC-157 therapy is designed to be simple and accessible
5 mg vial + 1 mL bacteriostatic water = 5 mg/mL 2 mg dose = 0.4 mL (40 units on a standard insulin syringe) 2.5 mg dose = 0.5 mL (50 units) 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL 2 mg dose = 0.8 mL (80 units) 2.5 mg dose = 1 mL (100 units, full syringe) 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL 2 mg dose = 0.4 mL (40 units) 2.5 mg dose = 0.5 mL (50 units) 5 mg dose = 1.0 mL (100 units) Most people stick with the 1 mL per 5 mg ratio because the numbers come out clean and easy to draw
Many user reports describe meaningful reductions in perceived recovery time, sometimes characterized as "cutting healing in half." Those claims are anecdotal rather than clinically validated, and outcomes vary by injury severity, age, sleep, nutrition, and rehab adherence